New study shows that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology.
Press release: Monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain as well as healthcare costs.
NOL pain response monitoring has been approved for marketing in Brazil.
A new study has found that monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain.
Medasense raises $18M in Series C round
A new economic study has shown that NOL technology is likely to help reduce the cost of care for hospitals.
Medasense Founder and CEO Galit Zuckerman-Stark has been named one of 13 finalists for the EU Prize for Women Innovators 2020.
NOL WEBINAR: Join leading experts in the field as they reveal the latest clinical evidence, insights and emerging applications!
Study validates NOL technology for assessment of pain in mechanically ventilated patients.
Medasense awarded a development grant to extend application of NOL monitoring for noncommunicating dementia patients.